Summit Global Investments Vertex Pharmaceuticals Inc Transaction History

Summit Global Investments

$1.6 Billion
Q4 2024

A detailed history of Summit Global Investments transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Summit Global Investments holds 4,977 shares of VRTX stock, worth $2.27 Million. This represents 0.13% of its overall portfolio holdings.

Number of Shares

4,977

Previous 5,790 14.04%

Holding current value

$2.27 Million

Previous $2.69 Million 25.58%

% of portfolio

0.13%

Previous 0.17%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 11, 2025	SELL	$396.64 - $516.74 $322,468 - $420,109	-813 Reduced 14.04%	4,977 $2 Million
Q3 2024 Oct 31, 2024	SELL	$460.0 - $505.78 $1.76 Million - $1.94 Million	-3,829 Reduced 39.81%	5,790 $2.69 Million
Q2 2024 Jul 22, 2024	SELL	$392.81 - $485.53 $12.7 Million - $15.7 Million	-32,290 Reduced 77.05%	9,619 $4.51 Million
Q1 2024 Apr 29, 2024	SELL	$407.69 - $446.08 $13.3 Million - $14.6 Million	-32,679 Reduced 43.81%	41,909 $17.5 Million
Q4 2023 Feb 06, 2024	BUY	$343.0 - $410.68 $7.93 Million - $9.49 Million	23,118 Added 44.92%	74,588 $30.3 Million
Q3 2023 Oct 13, 2023	BUY	$338.18 - $362.46 $15,556 - $16,673	46 Added 0.09%	51,470 $17.9 Million
Q2 2023 Jul 18, 2023	SELL	$314.42 - $351.91 $5.42 Million - $6.07 Million	-17,238 Reduced 25.11%	51,424 $18.1 Million
Q1 2023 May 04, 2023	BUY	$283.23 - $323.1 $77,321 - $88,206	273 Added 0.4%	68,662 $21.6 Million
Q4 2022 Jan 31, 2023	SELL	$285.76 - $321.48 $1.32 Million - $1.48 Million	-4,619 Reduced 6.33%	68,389 $19.7 Million
Q3 2022 Nov 14, 2022	SELL	$273.83 - $305.53 $2.15 Million - $2.4 Million	-7,841 Reduced 9.7%	73,008 $21.1 Million
Q2 2022 Aug 23, 2022	SELL	$234.96 - $292.55 $2.28 Million - $2.84 Million	-9,713 Reduced 10.73%	80,849 $22.8 Million
Q1 2022 Apr 29, 2022	SELL	$221.42 - $260.97 $992,404 - $1.17 Million	-4,482 Reduced 4.72%	90,562 $23.6 Million
Q4 2021 Feb 14, 2022	BUY	$177.01 - $223.45 $16.8 Million - $21.2 Million	95,044 New	95,044 $20.9 Million
Q3 2021 Nov 08, 2021	SELL	$181.39 - $202.99 $908,219 - $1.02 Million	-5,007 Closed	0 $0
Q2 2021 Jan 28, 2022	SELL	$187.49 - $221.1 $8.52 Million - $10 Million	-45,447 Reduced 90.08%	5,007 $986,000
Q1 2021 Jan 27, 2022	BUY	$207.02 - $241.31 $4.28 Million - $4.98 Million	20,657 Added 69.33%	50,454 $10.8 Million
Q4 2020 Feb 11, 2021	BUY	$207.01 - $276.09 $5.74 Million - $7.66 Million	27,731 Added 1342.26%	29,797 $7.04 Million
Q3 2020 Nov 16, 2020	SELL	$255.65 - $303.1 $4,601 - $5,455	-18 Reduced 0.86%	2,066 $562,000
Q2 2020 Aug 11, 2020	BUY	$225.48 - $295.8 $469,900 - $616,447	2,084 New	2,084 $605,000

Others Institutions Holding VRTX

# of Institutions

1,717

Shares Held

223M

Call Options Held

1.64M

Put Options Held

1.37M

View Full List

About VERTEX PHARMACEUTICALS INC

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $117B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

More about VRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Summit Global Investments, based on Form 13F filings with the SEC.

News

Stay updated on Summit Global Investments with notifications on news.

Account

Summit Global Investments Vertex Pharmaceuticals Inc Transaction History